Vanda Pharmaceuticals (VNDA) Return on Assets [ROA] (2009 - 2026)
Vanda Pharmaceuticals' Return on Assets [ROA] was -64.99% in Q2 2026, down 54.34 percentage points from -10.65% a year earlier and down 13.05 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Vanda Pharmaceuticals came in at -38.51%, down 35.61 percentage points from FY2024.
- Return on Assets [ROA] has now declined for four consecutive years, with a five-year change of -43.09 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -2.90% in FY2024 (-3.29 pp), 0.39% in FY2023 (-0.63 pp), 1.02% in FY2022 (-4.86 pp) and 5.88% in FY2021 (+1.29 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2014.
- Compared with a year earlier, Return on Assets [ROA] has declined for 11 straight quarters, with an average year-over-year change of -21.36 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2021 (a gain of 2.19 percentage points); the worst was Q2 2026 (a drop of 54.34 percentage points).
- Per Business Quant data, VNDA's Return on Assets [ROA] in the three quarters before Q2 2026 was -51.94% (Q1 2026), -40.45% (Q4 2025) and -13.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | -69.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -69.17% |
| Jun 30, 2026 | -64.99% |
| Mar 31, 2026 | -51.94% |
| Dec 31, 2025 | -40.45% |
| Sep 30, 2025 | -13.73% |
| Jun 30, 2025 | -10.65% |
| Mar 31, 2025 | -6.87% |
| Dec 31, 2024 | -2.90% |
| Sep 30, 2024 | -2.53% |
| Jun 30, 2024 | -1.67% |
| Mar 31, 2024 | -0.75% |
| Dec 31, 2023 | 0.39% |
| Sep 30, 2023 | 1.84% |
| Jun 30, 2023 | 2.31% |
| Mar 31, 2023 | 2.49% |
| Dec 31, 2022 | 1.00% |
| Sep 30, 2022 | 1.06% |
| Jun 30, 2022 | 1.81% |
| Mar 31, 2022 | 3.01% |
| Dec 31, 2021 | 5.63% |
API Access
Vanda Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();